BackEntrada Therapeutics Overview

Entrada Therapeutics Other Liabilities

Track Entrada Therapeutics's other liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Entrada Therapeutics Other Liabilities History

Loading

Entrada Therapeutics vs. peers: Other Liabilities Comparison

Loading

Entrada Therapeutics Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Entrada Therapeutics (TRDA) FAQ

The latest other liabilities for TRDA is $0 as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Entrada Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, TRDA's other liabilities moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Entrada Therapeutics's operating scale or balance-sheet position.

A other liabilities figure of $0 for TRDA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TRDA's other liabilities ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.